Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention.

Allison M GustavsonMarie E KennyJennifer P WisdomHope A SalamehPrincess E AcklandAdam J GordonHildi J Hagedorn

Published in: Addiction science & clinical practice (2021)

VHA facilities participating in 12-month external facilitation interventions experienced fluctuations in barriers to MOUD prescribing with contextual barriers emerging after a facilitated reduction in recipient- level barriers. Adoption of MOUD prescribing in low-adopting VHA facilities requires continual reassessment, monitoring, and readjustment of implementation strategies over time to meet challenges. Although i-PARIHS was useful in categorizing most barriers, the lack of conceptual clarity was a concern for some constructs.

Keyphrases

primary care
healthcare
randomized controlled trial
adverse drug
emergency department
smoking cessation
drug induced
replacement therapy